Literature DB >> 33201446

Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Evangelia Chalkiadaki1,2, Konstantinos Andreanos3, Efthymios Karmiris4, Chrysoula Florou3, Xanthi Tsiafaki5, Anastasia Amfilochiou5, Ilias Georgalas3, Chrysanthi Koutsandrea3, Dimitrios Papaconstantinou3.   

Abstract

PURPOSE: To study the effects of mean apnea-hypopnea duration (MAD), a useful indicator of blood oxygenation, on peripapillary retinal nerve fiber layer (RNFL), macular ganglion cell to inner plexiform layer (GC-IPL) and macular retinal thickness in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS).
METHODS: Sixty-five patients recently diagnosed with OSAHS and 35 healthy individuals were enrolled in this cross-sectional study. OSAHS patients were divided according to their MAD values into group 1 with 16 participants (MAD:10-15.5 s), group 2 with 17 participants (MAD:15.5-19 s), group 3 with 17 participants (MAD:19-30 s) and group 4 with 15 participants (MAD > 30 s). The average and sectorial values of RNFL, GC-IPL and retinal thickness were measured by SS-OCT (DRI OCT Triton, Topcon). Intraocular pressure was recorded by Goldmann Applanation and Pascal Dynamic Contour Tonometer (DCT-IOP).
RESULTS: The average RNFL and retinal thickness values were higher in group 4, but did not reach statistical significance. With the exception of the central 1 mm at the fovea, GC-IPL was always thickened in group 4, and significant differences were evident when its average value was compared with group 2 (p = 0.03), its superior and inferior-nasal values were compared with group 2 (p = 0.02, p = 0.006, respectively) and group 3 (p = 0.01, p = 0.02, respectively), its superior-temporal value was compared with group 3 (p = 0.003) and the control group (p = 0.03), and its superior-nasal value was compared with group 2 (p = 0.03), group 3 (p = 0.001) and the control group (p = 0.03). DCT-IOP was significantly positively correlated with the duration of sleep in which oxygen saturation (SaO2 ) was decreased under 90% (r = 0.359, p = 0.01).
CONCLUSION: We report a novel observation of GC-IPL thickening in OSAHS patients experiencing long MAD, a parameter which incorporates the severity of breathing events during sleep. Higher DCT-IOP was noted with advancing hypoxemia.

Entities:  

Keywords:  Mean apnea–hypopnea duration; Obstructive sleep apnea–hypopnea syndrome; Pascal dynamic contour tonometry; Retinal ganglion cells

Mesh:

Year:  2020        PMID: 33201446     DOI: 10.1007/s10792-020-01648-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  44 in total

1.  [Retinal nerve fiber layer thickness alterations in patients with obstructive sleep apnea].

Authors:  Pilar Calvo; Blanca Ferrández; Antonio Ferreras; José María Marín
Journal:  Arch Soc Esp Oftalmol       Date:  2012-01

Review 2.  Oxygen sensing in retinal health and disease.

Authors:  Clemens A K Lange; James W B Bainbridge
Journal:  Ophthalmologica       Date:  2011-09-22       Impact factor: 3.250

Review 3.  Pathophysiology of adult obstructive sleep apnea.

Authors:  Danny J Eckert; Atul Malhotra
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

Review 4.  Intermittent hypoxemia and OSA: implications for comorbidities.

Authors:  Naresh A Dewan; F Javier Nieto; Virend K Somers
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

5.  The relation between retrobulbar blood flow and posterior ocular changes measured using spectral-domain optical coherence tomography in patients with obstructive sleep apnea syndrome.

Authors:  Hüseyin Fındık; Metin Çeliker; Mehmet Gökhan Aslan; Fatma Beyazal Çeliker; Mehmet Fatih İnecikli; Engin Dursun; Murat Okutucu; Ünal Şahin
Journal:  Int Ophthalmol       Date:  2018-03-29       Impact factor: 2.031

Review 6.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

7.  Associations between Optic Disc Measures and Obstructive Sleep Apnea in Young Adults.

Authors:  Samantha S Y Lee; Nigel McArdle; Paul G Sanfilippo; Seyhan Yazar; Peter R Eastwood; Alex W Hewitt; Qiang Li; David A Mackey
Journal:  Ophthalmology       Date:  2019-05-17       Impact factor: 12.079

8.  Correlates of obstructive apnea duration.

Authors:  Brian B Koo; Ali Mansour
Journal:  Lung       Date:  2013-10-01       Impact factor: 2.584

9.  Apnea-Hypopnea Event Duration Predicts Mortality in Men and Women in the Sleep Heart Health Study.

Authors:  Matthew P Butler; Jeffery T Emch; Michael Rueschman; Scott A Sands; Steven A Shea; Andrew Wellman; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

10.  A Retrospective Study to Compare the Use of the Mean Apnea-Hypopnea Duration and the Apnea-Hypopnea Index with Blood Oxygenation and Sleep Patterns in Patients with Obstructive Sleep Apnea Diagnosed by Polysomnography.

Authors:  Xiaojun Zhan; Fang Fang; Chan Wu; Jayant M Pinto; Yongxiang Wei
Journal:  Med Sci Monit       Date:  2018-03-31
View more
  3 in total

Review 1.  Retinal microcirculation characteristics in obstructive sleep apnea/hypopnea syndrome evaluated by OCT-angiography: a literature review.

Authors:  Evita Evangelia Christou; Konstantinos Kostikas; Christoforos Asproudis; Paraskevas Zafeiropoulos; Maria Stefaniotou; Ioannis Asproudis
Journal:  Int Ophthalmol       Date:  2022-05-23       Impact factor: 2.031

2.  Effects of Obstructive Sleep Apnea-Hypopnea Syndrome and Cognitive Function in Ischemic Stroke Based on Linear Regression Equation.

Authors:  Peng Ji; Qixing Kou; Xueping Qu; Gen Sun; Songcan Liu; Jiewen Zhang
Journal:  Scanning       Date:  2022-06-22       Impact factor: 1.750

3.  Expression Profile Analysis and Image Observation of miRNA in Serum of Patients with Obstructive Sleep Apnea-Hypopnea Syndrome.

Authors:  Haiyan Shao; Peihong Shen; Junfeng Chen
Journal:  Contrast Media Mol Imaging       Date:  2021-12-14       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.